Episode Details

Vaccines for the Zaire ebolavirus have been licensed since 2019, but no such treatment exists for the current outbreak of Bundibugyo in the Democratic Republic of the Congo. In this episode: Anna Durbin, director of the Johns Hopkins Center for Immunization Research, introduces listeners to three candidate vaccines and discusses the hurdles to deploying new treatments.

Dr. Anna Durbin is a professor of International Health and the director of the Johns Hopkins Center for Immunization Research.

Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.

• Three Ebola vaccines in development amid growing outbreak fears—BBC

• USAID's closure led to 'entirely preventable' deaths, latest Ebola outbreak: House Dem report—The Hill

• HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapy—STAT

• Regeneron's Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak—Regeneron

• Listen Now